| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | CA2429329A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1206937A1 Nitroimidazole external preparations for dermatosis |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/22/2002 | EP1206478A1 Antisense modulation of mekk5 expression |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206462A2 Heterocyclic compounds inhibiting angiogenesis |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | EP1206448A1 Novel vitamin d analogues |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206436A2 Retinoids for the treatment of emphysema |
| 05/22/2002 | EP1206291A1 Sterilized cyanoacrylate solutions containing thickeners |
| 05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
| 05/22/2002 | EP1206269A1 Compositions and methods for the treatment of skin disorders |
| 05/22/2002 | EP1206267A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206242A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 05/22/2002 | EP1206234A2 Methods and compositions for modulating cell proliferation and cell death |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1147107A4 Novel angiogenesis inhibitors |
| 05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
| 05/22/2002 | EP0888349B1 Pyrrolopyrimidines and processes for their preparation |
| 05/22/2002 | CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
| 05/22/2002 | CN1350534A Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350528A 4,5,6,7-tetrahydroindazole derivatives as antitumor agents |
| 05/22/2002 | CN1350455A Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 05/22/2002 | CN1350435A A composition containing carvacrol and thymol for use as abactericide |
| 05/22/2002 | CN1085213C Triazole derivatives useful in therapy |
| 05/22/2002 | CN1085211C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/22/2002 | CN1085096C Ointment for curing burn, empyrosis and wound infection and preparation method thereof |
| 05/22/2002 | CN1085092C Technology for producing comedo eliminating liquid |
| 05/22/2002 | CN1085088C Drug for curing psoriasis |
| 05/22/2002 | CN1085087C External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof |
| 05/21/2002 | US6392071 Anticancer agents |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391879 Therapeutic anti-fungal nail preparation |
| 05/21/2002 | US6391874 Anticarcinogenic agents; skin disorders |
| 05/21/2002 | US6391850 Methods and compositions for inhibiting angiogenesis |
| 05/21/2002 | US6391322 Water-in-oil emulsion comprising aqueous phase dispersed in oily phase, at least one silicone emulsifier, and at least 5% by weight of one or more waxes |
| 05/21/2002 | US6391320 Cosmetic composition, for topical application to skin, hair, nails or eyelashes, containing at least one soluble protein fraction extracted from seed of bambara nut, in admixture with cosmetologically and dermatologically acceptable excipient |
| 05/21/2002 | US6391319 Cosmetic and dermatological emulsions comprising alkyl glucosides and increased electrolyte concentrations |
| 05/21/2002 | US6391289 Use of sunscreen combinations comprising, as essential constituent, 4,4′-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 05/21/2002 | US6391287 Storage stable compositions |
| 05/21/2002 | CA2223245C Catechol diethers derivatives useful as pharmaceutical agents |
| 05/21/2002 | CA1341359C Manufacturing process for a single-cell lifeform killing or growth inhibiting composition containing fluorine (f-) and lithium (li+) |
| 05/16/2002 | WO2002038778A1 Differentiation-inducing substances |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038528A1 Pleuromutilin derivatives with antimicrobial activity |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038150A1 ACTIVATORS OF PEROXISOME PROLIFERATOR-ACTIVATED α AND β RECEPTORS AS MEDICAMENTS FOR TREATING SKIN DISORDERS HAVING IMMUNOLOGICAL CAUSES |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002038123A1 A skin cream composition |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002017905A3 Treatment of burns |
| 05/16/2002 | WO2002013773A3 Cosmetic composition |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001095890A3 Oral pharmaceutical compositions containing terbinafine |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |